Smoking and COVID-19: Did we overlook representativeness?
作者信息
Wenzl Thomas
机构信息
European Commission, Joint Research Centre (JRC), Geel, Belgium.
出版信息
Tob Induc Dis. 2020 Nov 2;18:89. doi: 10.18332/tid/129584. eCollection 2020.
Abstract
摘要
相似文献
1
Smoking and COVID-19: Did we overlook representativeness?吸烟与2019冠状病毒病：我们是否忽略了代表性？
Tob Induc Dis. 2020 Nov 2;18:89. doi: 10.18332/tid/129584. eCollection 2020.
2
Nicotine and smoking in the COVID-19 era.新冠疫情时代的尼古丁与吸烟
J Cardiovasc Thorac Res. 2020;12(2):136-139. doi: 10.34172/jcvtr.2020.22. Epub 2020 May 28.
3
Let's not overlook nicotine.我们不要忽视尼古丁。
J Anal Toxicol. 1996 Mar-Apr;20(2):143. doi: 10.1093/jat/20.2.143.
4
Nicotine and apoptosis.尼古丁与细胞凋亡
Apoptosis. 2007 Nov;12(11):1927-43. doi: 10.1007/s10495-007-0102-8.
5
A population survey on legislative measures to restrict smoking in Ontario: 1. Design, methodology, and sample representativeness.安大略省限制吸烟立法措施的人口调查：1. 设计、方法及样本代表性。
Am J Prev Med. 1986 Nov-Dec;2(6):307-15.
6
Nicotine treatment and smoking cessation in the era of COVID-19 pandemic: an interesting alliance.2019冠状病毒病大流行时代的尼古丁治疗与戒烟：一个有趣的联盟。
ERJ Open Res. 2020 Aug 11;6(3). doi: 10.1183/23120541.00306-2020. eCollection 2020 Jul.
7
Managing long covid: don't overlook olfactory dysfunction.应对新冠长期症状：勿忽视嗅觉功能障碍。
BMJ. 2020 Sep 30;370:m3771. doi: 10.1136/bmj.m3771.
8
Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic.将戒烟作为一项公共卫生措施以限制2019年冠状病毒病大流行。
Eur Cardiol. 2020 Apr 23;15:e16. doi: 10.15420/ecr.2020.11. eCollection 2020 Feb.
9
Nicotine level as a predictor of smoking frequency: a case report.尼古丁水平作为吸烟频率的预测指标：一例报告
Int J Addict. 1984 Dec;19(8):827-32. doi: 10.3109/10826088409061988.
10
Transdermal nicotine replacement and smoking cessation.经皮尼古丁替代疗法与戒烟
Am Fam Physician. 1992 Jun;45(6):2595-602.
引用本文的文献
1
Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).2020-2021 年德国针对散发性 SARS-CoV-2 感染的行为和社会风险因素的病例对照研究（CoViRiS 研究）。
Epidemiol Infect. 2024 Jan 15;152:e16. doi: 10.1017/S0950268824000050.
2
Recognizing risk factors associated with poor outcomes among patients with COVID-19.识别与 COVID-19 患者不良预后相关的风险因素。
Prog Cardiovasc Dis. 2023 Jan-Feb;76:3-11. doi: 10.1016/j.pcad.2023.01.006. Epub 2023 Jan 21.
3
Nicotine has no significant cytoprotective activity against SARS-CoV-2 infection.尼古丁对 SARS-CoV-2 感染没有显著的细胞保护活性。
PLoS One. 2022 Aug 18;17(8):e0272941. doi: 10.1371/journal.pone.0272941. eCollection 2022.
4
Differences in Clinical Outcomes between Smokers and Non-Smokers infected with COVID-19.COVID-19 感染者中吸烟者和非吸烟者的临床结局差异。
Arch Razi Inst. 2022 Feb 28;77(1):449-459. doi: 10.22092/ARI.2021.356682.1894. eCollection 2022 Feb.
5
SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.从未吸烟、曾经吸烟和当前吸烟/使用尼古丁者中的SARS-CoV-2感染：一项对4040名埃及医护人员的队列研究。
BMC Public Health. 2021 Jun 28;21(1):1243. doi: 10.1186/s12889-021-11290-x.
6
Perceived health risks associated with the use of tobacco and nicotine products during the COVID-19 pandemic.2019冠状病毒病大流行期间与使用烟草和尼古丁产品相关的感知健康风险。
Tob Induc Dis. 2021 Jun 9;19:46. doi: 10.18332/tid/136040. eCollection 2021.
7
ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19.全国性的 ENE-COVID 血清学调查用于描述无症状感染，并制定基于症状的风险评分来预测 COVID-19。
J Clin Epidemiol. 2021 Nov;139:240-254. doi: 10.1016/j.jclinepi.2021.06.005. Epub 2021 Jun 11.
8
Cigarette and E-Cigarettes Dual Users, Exclusive Users and COVID-19: Findings from Four UK Birth Cohort Studies.香烟和电子烟双重使用者、单一使用者与 COVID-19：四项英国出生队列研究的结果。
Int J Environ Res Public Health. 2021 Apr 8;18(8):3935. doi: 10.3390/ijerph18083935.
9
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.影响新冠病毒相关基因在大气道上皮细胞中表达的遗传和非遗传因素。
Genome Med. 2021 Apr 21;13(1):66. doi: 10.1186/s13073-021-00866-2.
10
Response to the Comment on "A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19".关于“住院吸烟者与 COVID-19 的系统评价和荟萃分析”的评论的回复。
Int J Environ Res Public Health. 2020 Dec 21;17(24):9574. doi: 10.3390/ijerph17249574.
本文引用的文献
1
The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7).吸烟状况与SARS-CoV-2感染、COVID-19住院率及死亡率的关联：一项采用贝叶斯荟萃分析的实时快速证据综述（第7版）
Addiction. 2021 Jun;116(6):1319-1368. doi: 10.1111/add.15276. Epub 2020 Nov 17.
2
Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm.细胞因子释放综合征（CRS）与 COVID-19 患者的尼古丁：试图平息风暴。
Front Immunol. 2020 Jun 11;11:1359. doi: 10.3389/fimmu.2020.01359. eCollection 2020.
3
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.吸烟者和 COPD 患者小气道上皮中的 ACE-2 表达：对 COVID-19 的影响。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00688-2020. Print 2020 May.
4
Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).吸烟上调血管紧张素转换酶2受体：新型冠状病毒SARS-CoV-2（新冠病毒）的潜在粘附位点。
J Clin Med. 2020 Mar 20;9(3):841. doi: 10.3390/jcm9030841.
Zotero 插件